2022
DOI: 10.3390/nu14132625
|View full text |Cite
|
Sign up to set email alerts
|

Growth and Gastrointestinal Tolerance in Healthy Term Infants Fed Milk-Based Infant Formula Supplemented with Five Human Milk Oligosaccharides (HMOs): A Randomized Multicenter Trial

Abstract: Background: Five of the most abundant human milk oligosaccharides (HMOs) in human milk are 2′-fucosyllactose (2′-FL), 3-fucosyllactose (3-FL), lacto-N-tetraose (LNT), 3′-sialyllactose (3′-SL) and 6′-sialyllactose (6′-SL). Methods: A randomized, double-blind, controlled parallel feeding trial evaluated growth in healthy term infants fed a control milk-based formula (CF; n = 129), experimental milk-based formula (EF; n = 130) containing five HMOs (5.75 g/L; 2′-FL, 3-FL, LNT, 3′-SL and 6′-SL) or human milk (HM; n… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
30
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 29 publications
(30 citation statements)
references
References 37 publications
0
30
0
Order By: Relevance
“…Equivalence in weight gain (primary endpoint), length, and head circumference gain of up to 17 weeks was also confirmed with the test formula. There were no statistically significant differences between the formula groups for regurgitation, vomiting, watery, or hard stools at any timepoint 151 . Ramirez-Farias and colleagues 153 examined extensively hydrolyzed formula (eHF) with 2′-FL (0.2 g/L) for growth, tolerance, and compliance in a non-randomized, single-group, multicenter study.…”
Section: Hmos and Anthropometrymentioning
confidence: 76%
See 2 more Smart Citations
“…Equivalence in weight gain (primary endpoint), length, and head circumference gain of up to 17 weeks was also confirmed with the test formula. There were no statistically significant differences between the formula groups for regurgitation, vomiting, watery, or hard stools at any timepoint 151 . Ramirez-Farias and colleagues 153 examined extensively hydrolyzed formula (eHF) with 2′-FL (0.2 g/L) for growth, tolerance, and compliance in a non-randomized, single-group, multicenter study.…”
Section: Hmos and Anthropometrymentioning
confidence: 76%
“… Higher secretory immunoglobulin A and lower alpha-1-antitrypsin ( p < 0.05) in the test group in comparison to SFG. Vandenplas et al 151 2020 2’-FL, 3’-GL, scGOS/lcFOS Belgium, Hungary, Poland, Spain Ukraine 215 fully formula fed infants≤14 days old Infant formula contained 26% fermented formula with postbiotics derived from the Lactofidus fermentation process (including 3′-GL), 0.8 g/100 mL scGOS/lcFOS (9:1), and 0.1 g/100 mL 2′-FL Standard infant formula containing the oligosaccharides scGOS/lcFOS (0.8 g/100 mL; 9:1), but no 2′-FL, postbiotics, or milk fat. Breastfed infants Until 17 weeks of age Equivalence in weight gain between the test formula and control infant formula up to 17 weeks of age Supported an adequate growth, was well-tolerated, and no safety concerns were revealed given the absence of clinically relevant differences in the number adverse event.s Nowak-Wegrzyn et al 168 2019 2‘FL + LNnT United States 2017–2018 64 children with CMPA Aged 2 months to 4 years Extensively hydrolyzed formula with 1 g/L 2’-FL and 0.5 g/L LNnT Extensively hydrolyzed formula without HMOs 7–9 days The study formula met the clinical hypoallergenicity criteria.…”
Section: Hmos and Anthropometrymentioning
confidence: 99%
See 1 more Smart Citation
“…In the study of Parschat et al, the infection rate was 32/113 vs. 28/112 (p = 0.54) [36]. In the study of Lasekan et al, the antipyretic use was comparable (4/128 and 4/126), as was the antibiotic use (4/128 vs. 4/126) [38]. However, the study of Lasekan was conducted during the COVID-19 pandemic, where the infection rates in infants were generally low (7.6% of included patients), which is likely to have had an impact on these observations.…”
Section: Human Milk Oligosaccharidesmentioning
confidence: 92%
“…We retained six publications on human milk oligosaccharides (HMOs) (Table 3) [28,[34][35][36][37][38] involving a total of 1571 infants, conducted in America, Europe, and Asia. Five studies included only healthy term infants, and one study examined the effects of HMOs on infants with cow's milk allergy (CMA).…”
Section: Human Milk Oligosaccharidesmentioning
confidence: 99%